MedPath

Effects of two different exercise protocols for treating women with jaw pai

Not Applicable
Recruiting
Conditions
facial pain
K07.6
Registration Number
RBR-98b36rc
Lead Sponsor
niversidade Federal de São Carlos
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Women with TMD diagnosed by the DC/TMD criterea; Orofacial pain intensity higher than 3 points (NPRS); Onset of pain greater than 3 months;

Exclusion Criteria

Participants who start a new treatment in addition to the proposed one and participants who show signs and/or symptoms of exercise intolerance; pregnant women, or women undergoing hormone replacement; women who underwent some type of non-pharmacological treatment for TMD and neck pain in the last 6 months; irregular use of an interocclusal splint in the past 6 months; other causes of orofacial pain such as caries, periodontal diseases; or who had a history of head trauma that is related to the etiology of orofacial pain confounding the diagnosis of TMD; women with intracranial disorders; history of surgery in the orofacial or cervical region; continuous use of medications in the last 3 months such as muscle relaxants, anticonvulsants, beta blockers, bronchodilators, antidepressants and anxiolytics; female smokers or former smokers with less than 1 year of interruption; who have severe arrhythmias; obese (BMI>30km/m2); participants who present cardiovascular, respiratory, neurological and orthopedic diseases, which prevent the performance of physical exercise, or whose exacerbation is induced by physical exertion; neuropathies, fibromyalgia and rheumatic diseases.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of TMJ Pain Intensity measured by the Visual Analogue Scale; It is expected to find at the end of the treatment a variation of ate least 30% less pain.;Neck disability measured by the Neck Disability Index - It is expected to decrease the final score in ate least 5.5 points compared to baseline.
Secondary Outcome Measures
NameTimeMethod
Pressure pain thresholds of masticatory muscles measured by the algometer. A minimal detectable difference is expected for women with TMD of 0.18 kg/cm2 and 0.22 kg/cm2 in the masseters and temporalis, respectively.;Perception of change evaluated by the Global Rating of Change Scale of 11 points. ;Quality of life measured by the Oral Health Impact Profile (OHIP-14);Jaw Function evaluated by the Mandibular Function Impairment Questionnaire. It is expected at least 2 points of difference after the treatment.;Intensity of otological symptoms (tinnitus, earache, vertigo, dizziness, ear fullness and hearing loss) measured by a self reported numeric scale from 0 - 10.;Self-efficacy measured by the Chronic Pain Self-Efficacy Scale
© Copyright 2025. All Rights Reserved by MedPath